Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycolic Acid vs. Intradermal Tranexamic Acid for Melasma
NCT05362500Phase 1Completed
- Sponsor
- Combined Military Hospital Abbottabad
- Start
- Jun 2021
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of tranexamic acid and Glycolic acid in melasma, sponsored by Combined Military Hospital Abbottabad. Primary endpoint: Modified Melasma Severity Index at 12 weeks. Started Jun 2021; status: completed.
02
Drugs
tranexamic acidGlycolic acid
03
Conditions
melasma
Beyond the preview
Go deeper on NCT05362500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05362500.